Influence
January 9, 2020

Regenstrief VP breaking ground in artificial intelligence education in conjunction with National Academy of Medicine, other partners

Eneida Mendonca, Regenstrief Institute, VP for Research DevelopmentRegenstrief Vice President for Research Development Eneida Mendonca, M.D., PhD, is playing a crucial role in the creation of a groundbreaking publication on artificial intelligence in healthcare from the National Academy of Medicine. The document is viewed as a reference for all stakeholders involved in AI and healthcare. Dr. Mendonca is a co-lead on the chapter considering the tradeoffs and unintended consequences of AI and a co-author on the chapter exploring the deployment of AI in clinical settings. She stresses the importance of carefully monitoring the uses and outcomes after AI implementation to correct any negative consequences and the adoption of general IT governance structures to manage AI.  The publication is called “Artificial Intelligence in Health Care: The Hope, The Hype, The Promise, and The Peril.”

Related News

Christina Scifres, MD

Scifres named physician leader at IU Health

Role includes new Regenstrief Institute appointment, continuation of position at IU School of Medicine Christy Scifres, M.D., has been

Ontology 2.0 deepens LOINC®-SNOMED collaboration, speeds global lab interoperability

Ontology 2.0 deepens LOINC®-SNOMED collaboration, speeds global lab interoperability

INDIANAPOLIS, US and LONDON, UK – Regenstrief Institute and SNOMED International have released LOINC® Ontology 2.0, the next version

Kurt Kroenke, M.D., and Paul Musey, M.D., M.S.

Treating anxiety could curb unnecessary ED visits for low-risk chest pain

Chest pain ranks as the second most common reason for emergency department (ED) visits, making it a key concern